Altium Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-517,133
| Closed | -$2.15M | – | 116 |
|
|
2022
Q3 | $2.15M | Sell |
517,133
-177,867
| -26% | -$738K | 0.79% | 49 |
|
|
2022
Q2 | $2.79M | Hold |
695,000
| – | – | 1.12% | 30 |
|
|
2022
Q1 | $3.44M | Hold |
695,000
| – | – | 1.15% | 35 |
|
|
2021
Q4 | $4.84M | Buy |
695,000
+139,000
| +25% | +$969K | 1.34% | 26 |
|
|
2021
Q3 | $5.56M | Buy |
556,000
+299,848
| +117% | +$3M | 1.46% | 21 |
|
|
2021
Q2 | $3.63M | Sell |
256,152
-70,022
| -21% | -$993K | 0.84% | 44 |
|
|
2021
Q1 | $5.31M | Buy |
326,174
+23,000
| +8% | +$375K | 1.47% | 17 |
|
|
2020
Q4 | $6.28M | Buy |
+303,174
| New | +$6.28M | 2.34% | 3 |
|